文献速递腹部技术与安全CTMRUS

肝细胞癌监测与诊断影像策略的成本-效用分析

Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.
PubMed 文献 · AJR Am J Roentgenol · 2019-04-17

本研究用马尔可夫模型模拟肝硬化患者肝细胞癌监测与诊断的七种影像策略,并评估最佳与保守两种依从性场景。最佳依从性下,CT监测与诊断、CT不充分时补充完整MRI的策略E最具成本效用(13631加元/质量调整生命年);保守依从性下,简化MRI监测后CT补充或阳性时完整MRI的策略G最具成本效用(39681加元/质量调整生命年)。

要点

  • 最佳依从性下,CT监测与诊断、CT不充分时补充完整MRI(策略E)最具成本效用。
  • 保守依从性下,简化MRI监测、不充分时CT、阳性时完整MRI(策略G)最具成本效用。
  • 支付意愿阈值为每质量调整生命年50000加元(加拿大元)。

核心结论

  • 最佳依从性场景下,CT用于肝细胞癌监测与诊断、CT不充分时补充完整MRI最具成本效用。
  • 保守依从性场景下,简化MRI可能作为基于超声监测的替代方案。

研究设计与样本

  • 研究为马尔可夫模型模拟,比较肝硬化患者肝细胞癌监测与诊断的七种影像策略(策略A至G)。
  • 评估最佳与保守两种依从性场景,以每质量调整生命年50000加元(加拿大元)为支付意愿阈值判定最具成本效用策略,并进行敏感性分析。

诊断标准与关键数值

  • 策略E在最佳依从性场景下成本效用为13631加元/质量调整生命年,为最具成本效用策略。
  • 策略G在保守依从性场景下成本效用为39681加元/质量调整生命年,为最具成本效用策略。

局限性

  • 敏感性分析支持最佳依从性场景下的基础病例分析,但保守依从性场景下若干参数改变了最具成本效用策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study is to compare imaging-based surveillance and diagnostic strategies in patients at risk for hepatocellular carcinoma (HCC) while taking into account technically inadequate examinations and patient compliance. MATERIALS AND METHODS. A Markov model simulated seven strategies for HCC surveillance and diagnosis in patients with cirrhosis: strategy A, ultrasound (US) for surveillance and CT for diagnosis; strategy B, US for surveillance and complete MRI for diagnosis; strategy C, US for surveillance and CT for inadequate or positive surveillance; strategy D, US for surveillance and complete MRI for inadequate or positive surveillance; strategy E, surveillance and diagnosis with CT followed by complete MRI for inadequate surveillance; strategy F, surveillance and diagnosis with complete MRI followed by CT for inadequate surveillance; and strategy G, surveillance with abbreviated MRI followed by CT for inadequate surveillance or complete MRI for positive surveillance. Two compliance scenarios were evaluated: optimal and conservative. For each scenario, the most cost-effective strategy was based on a willingness-to-pay threshold of $50,000 (Canadian) per quality-adjusted life year (QALY). Sensitivity analyses were performed. RESULTS. Base-case analysis revealed that strategy E was the most cost-effective when compliance was optimal ($13,631/QALY), and strategy G was the most cost-effective when compliance was conservative ($39,681/QALY). Sensitivity analyses supported the base-case analysis in the optimal compliance scenario, but several parameters altered the most cost-effective strategy in the conservative compliance scenario. CONCLUSION. In an optimal compliance scenario, CT for HCC surveillance and diagnosis and complete MRI for inadequate CT was most cost-effective. In a conservative compliance scenario, abbreviated MRI may be an alternative to US-based surveillance.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lima PH, Fan B, Bérubé J, et al. Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma. AJR Am J Roentgenol. 2019. PMID: 30995098. doi:10.2214/AJR.18.20341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。